Jennison Associates
EPRS

Jennison Associates’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Jennison Associates’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,613,159
Closed -$7.03M – 688
2016
Q1 		$7.03M Buy
2,613,159
+15,291
+0.6% +$42.9K 0.01% 476
2015
Q4 		$8.03M Buy
2,597,868
+3,912
+0.2% +$17.6K 0.01% 495
2015
Q3 		$11.5M Sell
2,593,956
-36,986
-1% -$217K 0.01% 499
2015
Q2 		$15M Buy
2,630,942
+15,948
+0.6% +$109K 0.01% 488
2015
Q1 		$23.4M Buy
+2,614,994
New +$21M 0.02% 427
2014
Q4 		– Sell
-12,436
Closed -$89K – 803
2014
Q3 		$89K Buy
+12,436
New +$107K ﹤0.01% 717

Other funds holding EPRS

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return